Molecular and Cell Biological Analyzes of Structure and Function of Drug Transporters in the Intestine and Kidney Proximal Tubule

肠和肾近端小管药物转运蛋白结构和功能的分子和细胞生物学分析

基本信息

  • 批准号:
    06454596
  • 负责人:
  • 金额:
    $ 4.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Intestinal absorption and renal tubular secretion of ionic drugs are vectorial transcellular transport processes, which are mediated and regulated by transporters localized at the brush-border or basolateral membranes of these epithelia. In this project, we studied cDNA cloning, structure-function relationship and tissue distribution of drug transporters by using the PCR technique and expression system in Xenopus oocytes and mammalian transfectants.(1)cDNA cloining, functional characterization and tissue distribution of rat H^+/peptide contransporter : By PCR technique using degenerated primers based on amino acid sequence of the rabbit oligopeptide transporter PEPT1, a cDNA encoding for the rat H^+/peptide cotransporter PEPT1 has been isolated. The rat PEPT1 protein consisted of 710-amino acids with twelve membrane-spanning domains, and showed 77% and 83% amino acid identity with the rabbit and human PEPT1, respectively. Northern blot and reverse transcription-coupled PCR analyzes rev … More ealed that the rat PEPT1 messenger RNA was expressed predominantly in the small intestine, and to a lesser extent in the kidney cortex. By Western blot analysis using anti-rat PEPT1 antibody, rat PEPT1 was detected in duodenum, jejunum and ileum, but not in colon or rectum. Furthermore, rat PEPT1 was demonstrated to be localized at the brush-border membranes of both the small intestinal and renal proximal tubular cells, but not at the basolateral membranes of these epithelia. Transport studies using the oocytes injected with the synthetic rat PEPT1 RNA and the mammalian epithelial cells transfected with the rat PEPT1 cDNA indicated that the rat PEPT1 recognizes and transports orally active beta-lactam antibiotics such as ceftibuten (anion) and cephradine (zwitterion). These findings suggest that the rat PEPT1 mediates absorption of peptide-like drugs in the small intestine and kidney.cDNA cloning and characterization of kidney-specific organic anion transporter : By PCR technique using degenerated primers based on amino acid sequence of the rat liver organic anion transporter (oatp), a cDNA encoding for a novel rat organic anion transporter (OAT-K1) specifically expressed in the kidney was isolated. Functional studies by cultured epithelial cells transfected with the rat OAT-K1 cDNA demonstrated that OAT-K1 is localized at the basolateral membranes of renal proximal tubule and involved in the renal distribution and secretion of some anionic drugs.In conclusion, the findings obtained in this project will provide useful information for predicting tissue distribution of drugs and for development drug delivery systems. Less
离子药物的肠道抽象和肾小管分泌是矢量性跨细胞转运过程,这些过程是由位于这些上皮的刷子或基底外侧机制的转运蛋白介导和调节的。在该项目中,我们通过在异武卵母细胞和哺乳动物转化体中使用PCR技术和表达系统研究了药物转运蛋白的cDNA克隆,结构 - 连接关系和组织分布。(1)使用PCR技术的大鼠H^+/pcr技术的cDNA克隆,功能性表征和组织分布,基于PCR技术的频率序列: Pept1是分离的大鼠H^+/肽共转运蛋白PEPT1的cDNA。大鼠PEPT1蛋白由710个氨基酸组成,该氨基酸具有十二个跨膜结构域,分别显示出与兔和人类PEPT1的77%和83%的氨基酸同一性。 Northern印迹和逆转录耦合的PCR分析REV…更肯定地说,大鼠PEPT1 Messenger RNA主要在小肠中表达,并且在肾脏皮层中的程度较小。通过使用抗RAT PEPT1抗体的蛋白质印迹分析,在十二指肠,空肠和回肠中检测到大鼠PEPT1,但在结肠或直肠中未检测到。此外,大鼠PEPT1被证明位于小肠和肾近端结节细胞的刷状膜上,但不在这些上皮的基底外侧膜上。使用与大鼠PEPT1 cDNA翻译的合成大鼠PEPT1 RNA和哺乳动物上皮细胞注入的卵母细胞的转运研究表明,大鼠PEPT1识别和转运口服活性的β-乳糖酰胺抗生素,例如Ceftibuten(Ceftibuten(Ceftibuten)(阴离子)和Cephradine(Zwitterion)。 These findings suggest that the rat PEPT1 mediates absorption of peptide-like drugs in the small intestine and kidney.cDNA cloning and characterization of kidney-specific organic anion transporter : By PCR technique using degenerated primers based on amino acid sequence of the rat liver organic anion transporter (oatp), a cDNA encoding for a novel rat organic anion transporter (OAT-K1)在肾脏中特别表达。用大鼠燕麦蛋白cDNA翻译的培养的上皮细胞的功能研究表明,OAT-K1位于肾近端小管的基底外侧机制上,并参与了一些阴离子药物的肾脏分布和分泌。较少的

项目成果

期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H. Ogihara: "Immuno-localization of H^+/peptide cotransporter in rat digestive tract" Biochem. Biophys. Res. Commun.(in press). (1996)
H. Ogihara:“大鼠消化道中 H2/肽协同转运蛋白的免疫定位”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H. Saito: "Cloning and characterization of a rat H^+/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney" J. Pharmacol. Exp. Ther.275. 1631-1637 (1996)
H. Saito:“介导肠道和肾脏中 β-内酰胺抗生素吸收的大鼠 H^+/肽协同转运蛋白的克隆和表征”J. Pharmacol Exp. 1631-1637。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Matsumoto: "Transcellular transport of oral cephalosporins in human intestinal epithelial cells,Caco-2:Interaction with dipeptide transport systems in apical and basolaterl membranes" J.Pharmacol.Exp.Ther.270. 498-504 (1994)
S.Matsumoto:“口服头孢菌素在人肠上皮细胞中的跨细胞转运,Caco-2:与顶膜和基底膜中二肽转运系统的相互作用”J.Pharmacol.Exp.Ther.270。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
乾 賢一: "腎臓学-病態生理からのアプローチ,黒川清編" 南江堂, 442 (1995)
Kenichi Inui:“肾病学 - 病理生理学方法,黑川清编辑” Nankodo,442 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Tomita, M.Takano, M.Yasuhara, R.Hori and K.Inui: "Transport of oral cephalosporins by the H^+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells." J.Pharmacol.Exp.Ther.272. 63-69 (1995)
Y.Tomita、M.Takano、M.Yasuhara、R.Hori 和 K.Inui:“H2/二肽协同转运蛋白对口服头孢菌素的转运以及转运活性在离体兔肠上皮细胞中的分布。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INUI Ken-ichi其他文献

INUI Ken-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INUI Ken-ichi', 18)}}的其他基金

PHARMACOKINETICS IN THE PATIENTS WITH METABOLIC SYNDROME AND APPLICATION FOR PHARMACOTHERAPY
代谢综合征患者的药代动力学及其在药物治疗中的应用
  • 批准号:
    20249036
  • 财政年份:
    2008
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Establishment of personalized immunosuppressive therapy based on molecular mechanisms of transplant immunological network
基于移植免疫网络分子机制建立个体化免疫抑制治疗
  • 批准号:
    16209005
  • 财政年份:
    2004
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Evaluation of drug interaction and interindividual differences of renal drug excretion based on the genetic polymorphism analysis
基于遗传多态性分析评价药物相互作用及肾脏药物排泄个体差异
  • 批准号:
    13307068
  • 财政年份:
    2001
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular diversity of organic ion transporters and their roles in the renal drug excretion
有机离子转运蛋白的分子多样性及其在肾脏药物排泄中的作用
  • 批准号:
    11470495
  • 财政年份:
    1999
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of novel systems for evaluation and prediction of drug inteactions based on the reconstruction of drug excretion systems in vitro.
基于体外药物排泄系统重建的药物相互作用评估和预测的新系统的开发。
  • 批准号:
    09557211
  • 财政年份:
    1997
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molucular analysis of tissue distribution and structure-function relationship of transporters responsible for the regulation of drug transport
负责药物转运调节的转运蛋白的组织分布和结构功能关系的分子分析
  • 批准号:
    08457620
  • 财政年份:
    1996
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Kietic analysis and evaluation of drug absorption and excretion using cultured cells.
使用培养细胞进行药物吸收和排泄的动力学分析和评估。
  • 批准号:
    07557145
  • 财政年份:
    1995
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structure and Function of Drug Transporters in the Intestinal and Renal Epithelial Cells
肠和肾上皮细胞中药物转运蛋白的结构和功能
  • 批准号:
    02807200
  • 财政年份:
    1990
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regulation Mechanisms of Drug Disposition via H^+-Coupled Active Transport Systems in the Intestinal and Renal Tubular Epithelial Cells
肠和肾小管上皮细胞中H^耦合主动转运系统的药物处置调节机制
  • 批准号:
    63571092
  • 财政年份:
    1988
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

微塑料与β-内酰胺类抗生素联合暴露对耐药细菌胞外DNA生物转化的影响机制及其风险预测
  • 批准号:
    52370202
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
过氧乙酸/亚硫酸盐体系降解内酰胺类抗生素作用机制及对氯化消毒副产物的影响与控制
  • 批准号:
    52370009
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
Vidofludimus协同β-内酰胺类抗生素抗NDM-1阳性E.coli的作用机制研究
  • 批准号:
    32273060
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
Vidofludimus协同β-内酰胺类抗生素抗NDM-1阳性E.coli的作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
β-内酰胺类抗生素诱导促进ESBLs耐药质粒接合转移的分子调控机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Operating Grants
Serine/threonine kinase signaling in beta-lactam resistance of Staphylococcus aureus
金黄色葡萄球菌 β-内酰胺耐药中的丝氨酸/苏氨酸激酶信号传导
  • 批准号:
    10582130
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
Decoding the Mechanisms of Beta-Lactam Resistance in Streptococcus suis: A Genomic, Structural and Epidemiological Analysis.
解读猪链球菌β-内酰胺耐药机制:基因组、结构和流行病学分析。
  • 批准号:
    489695
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Operating Grants
Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms
开发针对 PBP3 的新型吡唑烷酮抗生素以克服耐药机制
  • 批准号:
    10590839
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
NMR crystallography: Imaging active site chemistry and protonation states
NMR 晶体学:对活性位点化学和质子化状态进行成像
  • 批准号:
    10406831
  • 财政年份:
    2022
  • 资助金额:
    $ 4.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了